MorphoSys to Host Q3 2011 Conference Call on October 28, 2011

MorphoSys to Host Q3 2011 Conference Call on October 28, 2011

ID: 78922

(Thomson Reuters ONE) -
MorphoSys AG /
MorphoSys to Host Q3 2011 Conference Call on October 28, 2011
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish its first
nine months' 2011 results on October 28, 2011 at 7:00am CEST.

At 2:00pm CEST (1:00pm BST, 8:00am EDT), the Management Board of MorphoSys AG
will host a public conference call and webcast to present MorphoSys's financial
results for the first nine months of 2011 and provide further details on the
Company's latest developments.



Dial-in numbers (listen only):

Germany:                       +49 89 2444 32975

United Kingdom:           +44 20 3003 2666

USA:                               +1 212 999 6659


An audio replay and manuscripts of the conference will be available on
www.morphosys.com/conference-calls in due course.


About MorphoSys:
MorphoSys developed HuCAL, the most successful antibody library technology in
the pharmaceutical industry. By successfully applying this and other patented
technologies, MorphoSys has become a leader in the field of therapeutic
antibodies, one of the fastest-growing drug classes in human healthcare. The
Company's AbD Serotec unit uses HuCAL and other technologies to generate
superior monoclonal antibodies for research and diagnostic applications.

Through its own development efforts and successful partnerships in the
pharmaceutical industry, MorphoSys has built a therapeutic pipeline of more than
70 human antibody drug candidates for the treatment of cancer, rheumatoid
arthritis, and Alzheimer's disease, to name just a few. With its ongoing
commitment to new antibody technology and drug development, MorphoSys is focused




on engineering the medicines of tomorrow. MorphoSys is listed on the Frankfurt
Stock Exchange under the symbol MOR. For regular updates about MorphoSys, visit
http://www.morphosys.com




HuCAL(®), HuCAL GOLD(®), HuCAL PLATINUM(®), arYla(®), CysDisplay(®) and
RapMAT(®) are registered trademarks of MorphoSys.


This communication contains certain forward-looking statements concerning the
MorphoSys group of companies. The forward-looking statements contained herein
represent the judgment of MorphoSys as of the date of this release and involve
risks and uncertainties. Should actual conditions differ from the Company's
assumptions, actual results and actions may differ from those anticipated.
MorphoSys does not intend to update any of these forward-looking statements as
far as the wording of the relevant press release is concerned.


For more information, please contact:

MorphoSys AG
Dr. Claudia Gutjahr-Löser
Head of Corporate Communications & IR
Tel: +49 (0) 89 / 899 27-122

Mario Brkulj
Senior Manager Corporate Communications & IR
Tel: +49 (0) 89 / 899 27-454

Jessica Kulpi
Specialist Corporate Communications & IR
Tel: +49 (0) 89 / 899 27-332

investors(at)morphosys.com




--- End of Message ---

MorphoSys AG
Lena-Christ-Str. 48 Martinsried / München Germany

WKN: 663200;ISIN: DE0006632003;Index:TecDAX,CDAX,Prime All Share,TECH All Share,HDAX,MIDCAP;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;


Q3 Conference Alert:
http://hugin.info/130295/R/1556951/480577.pdf




This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: MorphoSys AG via Thomson Reuters ONE

[HUG#1556951]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  DGAP-News: Vuzix Secures License to See-Through Optics Technology from Nokia Mobistar to offer iPhone 4S in Belgium on October 28th, 2011
Bereitgestellt von Benutzer: hugin
Datum: 21.10.2011 - 14:00 Uhr
Sprache: Deutsch
News-ID 78922
Anzahl Zeichen: 4763

contact information:
Town:

Martinsried / München



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 169 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"MorphoSys to Host Q3 2011 Conference Call on October 28, 2011"
steht unter der journalistisch-redaktionellen Verantwortung von

MorphoSys AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von MorphoSys AG



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z